State Board of Administration of Florida Retirement System’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.5M Buy
27,433
+5,914
+27% +$312K ﹤0.01% 1169
2026
Q1
$1.02M Buy
21,519
+158
+0.7% +$8.33K ﹤0.01% 1240
2025
Q4
$1.12M Hold
21,361
﹤0.01% 1202
2025
Q3
$1.38M Hold
21,361
﹤0.01% 1132
2025
Q2
$1.04M Buy
+21,361
New +$827K ﹤0.01% 1212

Other funds holding CRSP

State Board of Administration of Florida Retirement System's CRSP Position: Q2 2026 in Review

State Board of Administration of Florida Retirement System increased its CRISPR Therapeutics (CRSP) stake by 27% in Q2 2026, buying an estimated $312K and bringing the position to 27,433 shares worth $1.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1169.

State Board of Administration of Florida Retirement System first reported a position in CRSP in Q2 2025 and has held it in 5 quarters since. 304 funds tracked by Wall St. Rank hold CRSP as of Q2 2026.

  • State Board of Administration of Florida Retirement System held 27,433 shares of CRISPR Therapeutics worth $1.5M as of Q2 2026.
  • State Board of Administration of Florida Retirement System bought 5,914 CRISPR Therapeutics shares in Q2 2026, an estimated $312K.
  • CRISPR Therapeutics made up ﹤0.01% of State Board of Administration of Florida Retirement System's portfolio in Q2 2026, its #1169 holding.
  • State Board of Administration of Florida Retirement System first reported a position in CRISPR Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 304 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q2 2026.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q2 2026, filed 10 Aug 2026.